Progress in Palliative Care Beneift of Elderly Patients with Non-small Cell Lung Cancer
10.3779/j.issn.1009-3419.2015.07.11
- VernacularTitle:老年晚期非小细胞肺癌姑息治疗获益研究进展
- Author:
JIANG SHANTONG
1
;
LI PINGPING
Author Information
1. 北京大学肿瘤医院暨北京市肿瘤防治研究所中西医结合暨老年肿瘤科
- Keywords:
Lung neoplasms;
Elderly cancer;
Palliative care
- From:
Chinese Journal of Lung Cancer
2015;(7):462-468
- CountryChina
- Language:Chinese
-
Abstract:
Lung cancer is the leading cause of death among all cancers in China. It also has the highest incidence when compared to other cancers. Almost half of all lung cancers occur over 70-year-old. Approximately 85% of all lung cancers are non-small cell lung cancer (NSCLC). hTe majority of patients are advanced lung cancer. Due to the unique alterations in physiology, elderly patients are at a greater risk of toxicity from chemotherapy. Palliative care as a special medical care is an important treatment for elderly patients with advanced NSCLC. Low-dose palliative radiotherapy can improve respiratory symptoms in elderly patients with NSCLC, with the tolerated side effects. Elderly patients with epidermal growth factor recep-tor (EGFR) mutation can beneift from geiftinib and have a good tolerate of erlotiib. Cryocare Surgical System has an increasing trend of application in the treatment of elderly patients with NSCLC. Chinese medicine has effects in improving clinical symp-toms and reducing side effects of chemotherapy, it can also improve the quality of life in these patients. Psychosocial support therapy can alleviate the burden of patients with NSCLC to some extent, but needs to improve its systematicness. Assessment and the time of palliative care are two important factors which determine the outcome of patients. We introduce the progress in palliative care beneift of elderly NSCLC, in order to provide the basis for palliative care of elderly NSCLC.
